Cargando…

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study

OBJECTIVES AND BACKGROUND: The aim of this study was to identify determinants of submaximal exercise capacity as measured by 6 min walking distance in patients at risk for heart failure with preserved ejection fraction (HFpEF). METHODS: A cross‐sectional analysis from the prospective cohort programm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stahrenberg, Raoul, Duvinage, André, Mende, Meinhard, Gelbrich, Götz, auf der Heide, Wiebke, Düngen, Hans‐Dirk, Binder, Lutz, Nolte, Kathleen, Herrmann‐Lingen, Christoph, Hasenfuß, Gerd, Pieske, Burkert, Wachter, Rolf, Edelmann, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410539/ https://www.ncbi.nlm.nih.gov/pubmed/28834659 http://dx.doi.org/10.1002/ehf2.12034

Ejemplares similares

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2010)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

Erratum to: Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2011)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
por: Edelmann, Frank, et al.
Publicado: (2011)

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex‐DHF pilot study
por: Trippel, Tobias Daniel, et al.
Publicado: (2016)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study
por: Wachter, Rolf, et al.
Publicado: (2013)

A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure
por: Romppel, Matthias, et al.
Publicado: (2013)

High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia
por: Stahrenberg, Raoul, et al.
Publicado: (2013)

Excessive Supraventricular Ectopic Activity Is Indicative of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia
por: Weber-Krüger, Mark, et al.
Publicado: (2013)

Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany
por: Hashemi, Djawid, et al.
Publicado: (2020)

Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia – the Find-AF Study
por: Wachter, Rolf, et al.
Publicado: (2012)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
por: Fitz, Judith, et al.
Publicado: (2021)

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure
por: Wachter, Rolf, et al.
Publicado: (2009)

Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
por: Koschack, Janka, et al.
Publicado: (2008)

Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure
por: Sadlonova, Monika, et al.
Publicado: (2020)

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia
por: Mayer, Felix, et al.
Publicado: (2013)

Range Variability in CMR Feature Tracking Multilayer Strain across Different Stages of Heart Failure
por: Tanacli, Radu, et al.
Publicado: (2019)

Synthesis of CHF(2)-substituted 3-azabicyclo[3.1.0]hexanes by photochemical decomposition of CHF(2)-pyrazolines
por: Zheng, Yang, et al.
Publicado: (2018)

Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study
por: Gevaert, Andreas B., et al.
Publicado: (2022)

Heart failure awareness survey in Germany: general knowledge on heart failure remains poor
por: Zelenak, Christine, et al.
Publicado: (2017)

Reading Level and Suitability of Congestive Heart Failure (CHF) Education in a Mobile App (CHF Info App): Descriptive Design Study
por: Athilingam, Ponrathi, et al.
Publicado: (2019)

On soft submaximal spaces
por: Al Ghour, Samer, et al.
Publicado: (2022)

Growth-differentiation factor-15 and functional outcome after acute ischemic stroke
por: Gröschel, Klaus, et al.
Publicado: (2012)

Biatrial Remodeling in Patients with Cystic Fibrosis
por: Dordevic, Aleksandar, et al.
Publicado: (2019)

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Benini, Annachiara, et al.
Publicado: (2022)

Measuring dobutamine (Db) clearance during continuous hemofiltration (CHF)
por: Van der Linden, T, et al.
Publicado: (1998)

Electrocardiographic and other Noninvasive Hemodynamic Markers in Decompensated CHF Patients
por: Piccirillo, Gianfranco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hpt5jk6ufc6mv7fetf059kicul